医学
缺血性中风
药物治疗
冲程(发动机)
脑缺血
急性中风
心脏病学
内科学
重症监护医学
麻醉
缺血
组织纤溶酶原激活剂
机械工程
工程类
作者
Qi Li,Jinxiu Guo,Dawei Chen,Rolf Ankerlund Blauenfeldt,David C. Hess,Fernando Pico,Pooja Khatri,Bruce Campbell,Xinggang Feng,Mohamad Abdalkader,Jeffrey L. Saver,Raul G. Nogueira,Bingwu Jiang,Bing Li,Min Yang,Hongfei Sang,Qingwu Yang,Zhongming Qiu,Yi Dai,Thanh N. Nguyen
出处
期刊:Neurology
[Ovid Technologies (Wolters Kluwer)]
日期:2024-03-08
卷期号:102 (7): e207983-e207983
被引量:20
标识
DOI:10.1212/wnl.0000000000207983
摘要
In patients with ischemic stroke who are not eligible for reperfusion therapy, RIC did not affect mRS functional outcomes but significantly improved the NIHSS score at the follow-up endpoint and reduced stroke recurrence, without increasing the risk of cerebral hemorrhage or death. In patients who received IVT or MT, the benefit of RIC was not observed.
科研通智能强力驱动
Strongly Powered by AbleSci AI